A randomized long-term comparative study of clinical efficacy of α1-blocker with or without antiandrogen therapy for benign prostatic hyperplasia: Focusing on improvement of I-PSS

Acta Urologica Japonica

Volumn 46, Issue 11, 2000, Pages 791-797

  Ohtani, M ^a   Kikuchi, K ^a   Tsuchiya, A ^a   Noguchi, R ^a   Akaza, H ^a   Kondo, F ^a   Koiso, K ^a  

^a IBARAKI PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Benign prostatic hyperplasia; Chlormadinone acetate; Randomized comparative study; Tamsulosin hydrochloride

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIANDROGEN; CHLORMADINONE ACETATE; TAMSULOSIN;

ADULT; AGED; ARTICLE; BLADDER IRRITATION; BLADDER OBSTRUCTION; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; LONG TERM CARE; MALE; PROSTATE HYPERTROPHY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SYMPTOM; URINARY TRACT DISEASE; URINE FLOW RATE;

ADRENERGIC ALPHA-ANTAGONISTS; AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; CHLORMADINONE ACETATE; DRUG THERAPY, COMBINATION; HUMANS; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; SEVERITY OF ILLNESS INDEX; SULFONAMIDES; TIME FACTORS; TREATMENT OUTCOME; URODYNAMICS;

EID: 0034519608     PISSN: 00181994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia
2. Tamsulosin and chlormadinone for the treatment of benign prostatic hyperplasia